会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明专利
    • Composition for oral administration
    • 口服药物组合物
    • JP2007045771A
    • 2007-02-22
    • JP2005232929
    • 2005-08-11
    • Pola Chem Ind Incポーラ化成工業株式会社
    • FUKUDA TOSHIYUKIMITANI MAKOTO
    • C07H15/18A23L1/30A61K31/7034A61K31/7048A61K36/73A61P7/02
    • PROBLEM TO BE SOLVED: To provide a technique for suppressing plasminogen activator inhibitor (PAI) by a specific food component.
      SOLUTION: The composition for oral administration for the suppression of plasminogen activator inhibitor contains an extract of the flower and/or flower bud of a plant of the genus Prunus, family Rosaeae, preferably Prunus persica and/or Prunus davidiana, as an active component. The extract is produced preferably by extracting the vegetable with hydrated ethanol, removing the extraction solvent, removing n-hexane-soluble component, ethyl acetate-soluble component and n-butyl alcohol-soluble component in the presence of water phase, and removing water from the remaining water phase. The extract preferably contains one or more substances selected from prunacic acid, neoprunacic acid, multinoside A, multiflorine B and their salts as drug active components.
      COPYRIGHT: (C)2007,JPO&INPIT
    • 待解决的问题:提供通过特定食品成分抑制纤溶酶原激活物抑制剂(PAI)的技术。 解决方案:用于抑制纤溶酶原激活物抑制剂的口服给药组合物含有植物的花和/或花蕾的提取物,属于植物,如玫瑰花科,优选山梨属植物和/或山梨属(Prunus davidiana),作为 活性组分。 提取物优选通过用水合乙醇萃取植物,除去萃取溶剂,在水相存在下除去正己烷可溶成分,乙酸乙酯可溶成分和正丁醇可溶成分, 剩余的水相。 提取物优选含有一种或多种选自prunacic acid,neoprunacic acid,multinoside A,multiflorine B及其盐作为药物活性成分的物质。 版权所有(C)2007,JPO&INPIT